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Abstract
In contrast to studies in women, male osteoporosis is poorly understood and strictly related to advancing age.
Among the first antiresorptive substances used in the prevention and treatment of osteoporosis is calcitonin
(CT), a hypocalcemic hormone that potently inhibits osteoclastic bone resorption. Natural CT is produced and
secreted by thyroid C-cells. The other endocrine population of thyroid cells produces thyroid hormones (TH),
which also affect bone turnover. The aim of this study was to evaluate the influence of salmon CT on
trabecular bone microarchitecture with special reference to effects on the structure and function of both CT-
and TH-producing thyroid cells in orchidectomized (Orx) middle-aged rats. Twenty-four male Wistar rats aged
15 months were randomly divided into Orx and sham-operated (SO) groups. One group of Orx animals received
(s.c.) synthetic salmon CT (Orx + CT; 100 IU kg1 b.w.) subcutaneously every second day for 6 weeks. The
second Orx group and SO rats were given the same volume of vehicle alone by the same schedule. Trabecular
bone histomorphometrical parameters were: cancellous bone area (B.Ar), trabecular thickness (Tb.Th),
trabecular number (Tb.N) and trabecular separation (Tb.Sp) were obtained with an IMAGEJ public-domain image-
processing program. The peroxidase–antiperoxidase method was applied for localization of CT in C-cells. Anti-
human CT antisera served as the primary antibodies. For immunohistochemical characterization of vascular
endothelial growth factor (VEGF) in thyroid tissue, rabbit antisera against human VEGF, served as primary
antibodies. CT-immunopositive thyroid C-cells, thyroid follicular epithelium, interstitium and colloid were
evaluated morphometrically. Blood serum samples were analyzed for CT, osteocalcin (OC), and thyroxine (T4),
and calcium (Ca2+) concentration was determined in urine samples. Salmon CT application significantly
increased B.Ar, TbTh and TbN, but markedly decreased Tb.Sp. Administration of exogenous CT significantly
decreased mean volume (Vc) and relative volume density (Vv) of thyroid C-cells in relation to both SO and Orx
groups. The Vv of the colloid was higher, whereas the VV of the follicular epithelium was lower after CT
treatment compared with Orx alone. CT treatment markedly elevated serum CT, whereas serum OC, T4 and
urinary Ca2+ concentrations were lower than in the Orx group. These results indicate that salmon CT stimulates
trabecular bone microarchitecture, strongly inhibits thyroid C-cells and changes the structure of the thyroid
gland, indicating hypoactivity.
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Introduction
Osteoporosis is a skeletal disorder characterized by unbal-
ancedbone remodelingactivity. This causesmicroarchitectural
deterioration of the bone and progressive decrease in
bone density. Although this disease affects both sexes,
age-related bone loss in men is much less investigated than
in women. Unlike menopausal women, there is no dra-
matic decline in sex hormone levels in men, but the contin-
uous slow reduction in circulating androgens is associated
with bone loss (Swerdloff &Wang, 2002). Male osteoporo-
sis is related to advancing age and starts later in life than in
women (Rochira et al. 2006). Although osteoporosis in
males is caused by androgen deficiency, estrogens have a
greater bone-protecting effect than testosterone. Most of
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the estrogen in men is derived from aromatization of
androgens by the enzyme aromatase in different tissues
(Simpson & Dowsett, 2002). Even though the number of
studies on the pathophysiology of bone in men has
increased in recent years, this phenomenon remains poorly
understood. Hence, there is a need for additional research
to better understand this condition inmen.
Different antiresorptive and anabolic agents have been
used to prevent and treat osteoporosis. One of the first
antiosteoporotic therapeutics was calcitonin (CT), a hypocal-
cemic peptide hormone that regulates serum calcium levels.
It acts as an antiresorptive agent by directly inhibiting
osteoclast-mediated bone resorption and by increasing cal-
cium excretion through the kidney (Warshawsky et al.
1980). Among synthetic CT preparations from different spe-
cies, salmon CT is the most widely employed in clinical prac-
tice due to its much greater potency compared with human
CT (Azria et al. 1995). Treatment with salmon CT increased
bone mineral density, enhanced bone biomechanical prop-
erties and accelerated healing of bone fractures in osteo-
porotic rat models (Li et al. 2007; Bulbul et al. 2008).
Mammalian CT is produced by thyroid gland C-cells
(Pearse, 1966), the activity of which was suggested to be
regulated by circulating gonadal hormone concentrations
(Foresta et al. 1985; Greenberg et al. 1986). Sex steroid-defi-
cient gonadectomized rats are animal models of osteoporo-
sis because thyroid C-cell activity is inhibited in both
females (Sakai et al. 2000; Filipovic et al. 2003) and males
(Lu et al. 2000; Filipovic et al. 2007). On the other hand,
thyroid follicular cells synthesize and secrete thyroxine and
triiodothyronine, which have important roles in skeletal
homeostasis and bone mass regulation (Yen, 2001). Thyroid
hormones (TH) activate bone resorption (Kanatani et al.
2004). Sex steroids regulate TH homeostasis, which may
change during aging. In the rodent model of osteoporosis
the effects of sex hormone deficiency after gonadectomy
may differ depending on age and gender (Banu et al. 2001,
2002; Sosic-Jurjevic et al. 2012).
There is little available information about the use of CT in
the treatment of male osteoporosis, although CT has shown
beneficial effects on bone in postmenopausal osteoporosis
(Gruber et al. 1984). The pathogenesis of male osteoporosis
differs from that of postmenopausal osteoporosis and
agents that are effective in women may not be effective in
men (Trovas et al. 2002). Since there are few studies about
the pathogenesis of male osteoporosis, additional research
is needed to gain an understanding of the mechanisms of
action of some remedies used to treat this bone disease.
Considering that both CT and TH produced by the thyroid
play important roles in the regulation of bone mass, the aim
of this study was to determine the effects of exogenous CT
administration on trabecular bone microarchitecture but
with special reference to structural and functional changes
and potential interactions of the two different thyroid endo-
crine cell populations in a rat model of male osteoporosis.
Materials and methods
Animals and experimental design
MaleWistar rats were housed at the Institute for Biological Research,
Belgrade, Serbia, and maintained with free access to food and water
in a 12/12 h light/dark cycle at 22  2 °C. Twenty-four (15-month-
old) male rats were divided into three groups: sham operated control
(SO), orchidectomized control (Orx), and Orx rats treated with calci-
tonin (Orx + CT). The animals were bilaterally orchidectomized or
sham operated under ketamine anesthesia (15 mg kg1 b.w.). Two
weeks after surgery, one group of Orx animals (n = 8) was given syn-
thetic salmon calcitonin (ICN, Galenika Pharmaceutical Works, Bel-
grade, Serbia) subcutaneously (s.c.) at 100 IU kg1 b.w. every second
day for 6 weeks. The second Orx (n = 8) and SO (n = 8) groups sub-
cutaneously received the same volume of vehicle alone. The animals
were killed 24 h after the last injection. Serum was separated from
trunk blood and urine samples, collected 24 h before sacrifice, and
stored at 70 °C until required for biochemical analysis. All animal
procedures complied with the EEC Directive (2010/63/EU) on the pro-
tection of animals used for experimental and other scientific pur-
poses, and were approved by the Ethical Committee for the Use of
Laboratory Animals of the Institute for Biological Research, ‘Sinisa
Stankovi’ University of Belgrade, Serbia.
Bone histomorphometry
Rat proximal tibia samples were excised, cleaned of soft tissue and
fixed in Bouin’s solution for 5 days. After fixation, the specimens
were decalcified in 20% EDTA (ethylenediaminetetra-acetic acid dis-
odium salt) solution in distilled water, pH 7.4, for 2–4 weeks with
renewal of the solution every second day. Thereafter, tibias were
routinely processed and embedded in paraplast. Each tissue block
was placed in a rotation microtome (RM 2125; Leica, Germany) with
microtome blades for hard section (Sakura Finetek, Japan) and cut
longitudinally followed by staining using the Azan method, as pre-
viously described (Filipovic et al. 2007).
Histomorphometry was performed with an IMAGEJ public-domain
image-processing program. The area of the secondary spongiosa of
the analyzed metaphyseal region included the part within 1 mm dis-
tal to the epiphyseal growth plate. The histomorphometric parame-
ters and the calculations employed are those described in the Report
of the American Society for Bone and Mineral Research Committee
Histomorphometry Nomenclature (Parfitt et al. 1987). The data
automatically obtained by the image analysis system were used to
calculate the cancellous bone area (B.Ar) and cancellous bone
perimeter (Evans et al. 1994). Trabecular thickness (Tb.Th), trabecu-
lar number (Tb.N) and trabecular separation (Tb.Sp) were derived
from these parameters as described earlier (Filipovic et al. 2007).
Immunohistochemistry
The thyroid lobes were excised, fixed in Bouin’s solution for 24 h
and embedded in paraplast. A rotatory microtome are used for cut-
ting 5-lm-thick longitudinal sections of fixed thyroid tissue. The
peroxidase-antiperoxidase (PAP) method was used for immunohis-
tochemical detection of CT in thyroid C-cells (Sternberger
et al.1970). Anti-human CT antisera (Dakopatts, Copenhagen, Den-
mark, Lot No. 020) diluted 1 : 500 served as the primary antibodies.
For immunohistochemical characterization of vascular endothe-
lial growth factor (VEGF) in thyroid tissue, rabbit antisera against
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human VEGF (Abcam, Cambridge, UK, Lot No. GR247559-1) diluted
1 : 100 and applied overnight at 4 °C, served as primary antibodies.
Antigen-antibody complexes were visualized by incubating tissue
sections with diaminobenzidine tetrahydrochloride (DAB; Dako-
patts, Glostrup, Denmark). The incubated sections were counter-
stained with hematoxylin and mounted with DPX (Sigma-Aldrich,
Barcelona, Spain).
Stereological analysis
Thyroid gland sections were stereologically analyzed by a point-
counting method (Weibel 1979). We determined the mean volume
(Vc; lm3) and relative volume density (volume of C-cells per unit vol-
ume of thyroid gland; Vvc; %) of calcitonin immunoreactive thyroid
C-cells. Also, the relative volume density (Vv; %) of the correspond-
ing thyroid tissue components (follicular epithelium, interstitium
and colloid), defined as the ratio of this component in a volume
unit, was calculated. All parameters were measured in 50 test fields
of thyroid gland using the M42 multipurpose test grid inserted into
the ocular of a Zeiss light microscope (Jena, Germany), at a total
magnification of 10009 for C cells and 4009 for other thyroid com-
ponents.
Serum and urine biochemical parameters
Serum samples from all experimental groups were used for determi-
nation of osteocalcin (OC), CT and thyroxine (T4) concentrations.
The 24-h urine collections from each group were used for measure-
ment of calcium (Ca2+) concentration. Serum CT levels were deter-
mined immunochemiluminometrically (Nichols, USA) using a mouse
monoclonal antihuman CT antibody marker with acridium ester.
The luminescence was quantified with a semiautomated MLA 1
chemiluminescence analyzer (Ciba-Corning). Serum concentrations
of T4 were determined by ELISA (HUMAN, Wiesbaden, Germany).
All serum samples were measured in duplicate within a single assay.
The intra-assay coefficient of variation was 8–8.7%. Serum OC levels
were determined by electrochemiluminescence using a Roche Elec-
sys 2010 immunoassay analyzer (Roche Diagnostics GmbH, Man-
nheim, Germany). Serum Ca and P levels and urinary Ca2+
concentration were determined on a Hitachi 912 analyzer (Roche
Diagnostics GmbH).
Statistical analysis
The data were analyzed with STATISTICA 6.0 software (Statsoft, Tulsa,
OK, USA). The Kolmogorov–Smirnov test was used to determine
potential deviation from normal distribution, followed by one-way
analysis of variance (ANOVA). Duncan’s multiple range test was
employed for post hoc comparisons between groups. Differences
between mean values were considered to be significant at P < 0.05.
The data are presented as means  standard error of the mean
(SEM).
Results
Trabecular bone microarhitecture after calcitonin
treatment
We assessed the effect of CT treatment on bone structure
parameters in the proximal tibia metaphysis of Orx middle-
aged rats. Previously, we showed that trabecular bone mass
declined markedly after Orx (Filipovic et al. 2007). In the
CT-treated Orx group, trabecular bone mass was increased,
as reflected by numerous well developed trabeculae when
compared with proximal tibiae from untreated Orx rats. His-
tological features of trabecular bone tissue after CT applica-
tion were similar to the trabecular bone microarchitecture
seen in control SO animals (Fig. 1A–C). After CT treatment,
B.Ar, TbTh and TbN were increased by 176, 35 and 28%
(P < 0.05), respectively; but Tb.Sp had diminished by 27%
(P < 0.05) when compared with the Orx group. There were
no significant differences in microstructural parameters of
trabecular bone after calcitonin treatment in SO animals
(Fig. 1D).
Thyroid C-cells after calcitonin treatment
Calcitonin-producing thyroid C-cells in SO animals were
numerous and distributed as large clusters with light-
colored granular cytoplasm (Fig. 2A). After Orx, C-cells with
darker cytoplasm were much less abundant than in the SO
group (Fig. 2B). The majority of C-cells in Orx animals trea-
ted with CT appeared as less numerous individual cells with
a thin layer of dark cytoplasm around the nucleus (Fig. 2C).
Stereological analysis showed that treatment of Orx rats
with CT significantly decreased both Vc and Vvc by 14 and
15% (P < 0.05), respectively, when compared with the con-
trol Orx rats. Also, CT treatment markedly reduced both
parameters (Vc and Vvc) by 26% (P < 0.05) in relation to SO
(Fig. 2D). We have already reported a significant decrease
in Vc and Vvc of thyroid C-cells in Orx rats when compared
with SO animals (Filipovic et al. 2007).
Thyroid follicular cells and VEGF immunoreactivity
after calcitonin treatment
Within thyroid tissue, TH-producing cells are organized in
angiofollicular units, composed of follicles and surrounding
vasculature. Follicles vary in size and shape, in correlation
with their function in hormone production. In SO controls,
the follicular epithelium was mainly cuboidal, surrounding
relatively large portions of luminal colloid. Numerous C-cells
characterized by large, light nuclei and usually grouped in
large clusters adjacent to thyroid follicles could be easily dis-
tinguished on hematoxylin and eosin-stained sections
(Fig. 3A). Orchidectomy of middle-aged males did not
induce significant histomorphometric changes in thyroid
follicles when compared with age-matched SO controls
(Fig. 3B). However, after CT treatment the follicles were
extended and filled with more colloid than in either Orx or
SO controls (Fig. 3C). Stereological analysis showed that the
relative VV of the colloid was 27% higher (P < 0.05),
whereas VV of the follicular epithelium was 13% lower
(P < 0.05) in the Orx+CT group than the value obtained for
the Orx group (Fig 3D).
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VEGF is a major paracrine factor that regulates angiogen-
esis and vascular permeability and we studied VEGF-immu-
nopositivity as an indirect measure of the activity of the
vascular component within angiofollicular units. VEGF-
immunopositivity was granular and uniformly distributed in
the cytoplasm of thyrocytes, being weakest in the Orx-CT
group, which had a flattened follicular epithelium (Fig. 4).
Serum and urine parameters after calcitonin
treatment
Administration of salmon CT to Orx rats lowered serum OC
and urinary Ca2+ concentrations by 61 and 63% (P < 0.05),
respectively, in comparison with the Orx group (Fig. 5A,B).
Serum CT concentration was elevated by 247 and 60%
(P < 0.05), respectively, after CT treatment in comparison
with the Orx and SO groups (Fig. 5C), whereas serum T4
was 17% lower (P < 0.05) than in Orx rats (Fig. 5D). We
have already shown that Orx markedly decreased serum CT
and urinary Ca2+ concentrations, whereas serum OC was
higher than in the control SO animals (Filipovic et al. 2007).
Discussion
Unlike postmenopausal osteoporosis, the pathogenesis of
male osteoporosis and mechanisms of action of anti-osteo-
porotic therapeutics are very poorly understood. As a
potent inhibitor of osteoclastic bone resorption and pro-
moter of bone fomation, the hypocalcemic hormone, CT,
has been used to treat many bone disorders including
A B C
D
Fig. 1 Proximal tibial metaphyses from: (A) sham-operated (SO) rats, (B) orchidectomized (Orx) rats and (C) orchidectomized rats treated with
salmon calcitonin (Orx + CT). Azan method stain. (D) Cancellous bone area (B.Ar), trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecu-
lar separation (Tb.Sp). All values are mean  SEM. Filled circle: P < 0.05 vs. SO. Asterisk: P < 0.05 vs. Orx.
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osteoporosis (Arisawa et al. 2008). Natural CT is a 32-amino
acid peptide hormone secreted by thyroid C-cells (Pearse,
1966). TH-producing thyroid follicular cells also have
marked effects on bone tissue metabolism (Yen, 2001).
Besides trabecular bone, the main purpose of this study was
to examine the effect of salmon CT on the structure and
function of both thyroid C-cells and follicular cells, as their
hormone products each have significant roles in bone mass
regulation.
As a model of male osteoporosis we evaluated the effect
of salmon CT treatment on trabecular bone microarchitec-
ture in middle-aged Orx rats. Previously, we demonstrated
a reduction of trabecular bone mass in androgen-deficient
male rats (Filipovic et al. 2007). Here we found that treat-
ment with salmon CT markedly improved bone structure
parameters. Thus, B.Ar, Tb.Th and Tb.N were increased but
Tb.Sp was decreased in relation to values for the control
Orx rats. Moreover, serum OC and urinary Ca2+ concentra-
tions were significantly lower than in Orx rats. These results
are in line with those of others using rats, which confirms
the bone-protective effects of salmon CT in this species (Li
et al. 2007; Bulbul et al. 2008) and the few studies on the
effect of this hormone on bone turnover in osteoporotic
men (Trovas et al. 2002).
Calcitonin is a potent inhibitor of osteoclastic bone
resorption and this action is mediated in part by binding to
osteoclast membrane receptors (Nicholson et al. 1986). This
hormone directly causes loss of the ruffled border of
osteoclasts in vitro (Chambers & Magnus, 1982), reduces
osteoclast number and motility (Zaidi et al. 1990; Gao &
Yamaguchi, 1999) and inhibits osteoclast secretory activity,
such as synthesis and release of tartrate-resistant acid phos-
phatase (Yumita et al. 1991). In addition to osteoclasts, CT
interacts with osteoblasts by inducing their proliferation
(Villa et al. 2003) and may prevent osteoblast and osteocyte
apoptosis (Plotkin et al. 1999). Also, CT is able to induce
increased secretion of insulin-like growth factor in osteo-
blasts (Farley et al. 2000). The fact that CT receptors are
expressed on osteoblasts indicates that CT acts through its
own receptors (Villa et al. 2003).
Fig. 2 Calcitonin-immunostained thyroid C-cells from: (A) sham-operated (SO) rats, (B) orchidectomized (Orx) rats and (C) orchidectomized rats
treated with salmon calcitonin (Orx + CT). Immunoperoxidase staining specific for calcitonin. (D) Cellular volume (Vc) of immunoreactive C-cells,
volume density of immunoreactive C-cells (Vvc). All values are mean  SEM. Filled circle: P < 0.05 vs. SO. Asterisk: P < 0.05 vs. Orx.
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In addition to the influence of salmon CT on trabecular
bone microarchitecture, we investigated its effects on the
activity of CT- and TH-secreting thyroid cell populations. Sex
steroid deficiency in gonadectomized models of osteoporo-
sis has already been shown to affect thyroid C-cell structure,
and reduce the synthesis and release of CT and TH
A B
C D
Fig. 3 Thyroid gland from: (A) sham-operated (SO) rats, (B) orchidectomized (Orx) rats and (C) orchidectomized rats treated with salmon calcitonin
(Orx + CT). Hematoxylin-eosin stain. (D) Relative volume density (Vv) of thyroid follicular epithelium, interstitium and colloid. All values are mean 
SEM. Filled circle: P < 0.05 vs. SO. Asterisk: P < 0.05 vs. Orx.
A B C
Fig. 4 Immunohistochemical staining of vascular endothelial growth factor (VEGF) in the thyroid gland from: (A) sham-operated (SO) rats, (B)
orchidectomized (Orx) rats and (C) orchidectomized rats treated with salmon calcitonin (Orx + CT).
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homeostasis in female and male rats (Banu et al. 2001,
2002; Filipovic et al. 2003, 2007; Sosic-Jurjevic et al., 2012).
In this study, we demonstrated that treatment of Orx rats
with salmon CT further decreased the already reduced Vc
and Vvc of thyroid C-cells, whereas serum CT was elevated
due to Orx. This inhibitory effect of exogenous CT on rat
thyroid C-cell function and proliferation was described ear-
lier (Morimoto et al. 1984; Mori et al. 2003). Exogenous CT
suppresses C-cell function probably by involving a negative
feedback mechanism. The mRNA for CT receptors has been
shown to be expressed in both tissue and cell lines of
human medullary thyroid carcinoma (Frendo et al. 1998a,
b). Therefore, CT may act directly via its own receptors on
C-cells (Mori et al. 2003). Under our experimental condi-
tions, CT treatment also affected the overall structure of rat
thyroid glands. Thus, the large accumulations of colloid in
the follicles, low cuboidal epithelium of TH-producing
follicular cells, diminished levels of T4 and weaker VEGF-
immunopositivity compared with control Orx rats indicated
thyroid gland hypoactivity. Published data regarding the
effect of CT treatment on thyroid cells, especially thyroid
follicular cells, are scarce and often contradictory. Some
data support an indirect action of exogenous CT on the
activity of TH-producing thyroid cells through reduced TSH
concentration in both humans (Leicht et al. 1974) and rats
(Ishii et al. 1991). Also, processes such as thyroid growth are
inhibited by CT (Rybicka et al. 1992). It is possible that C-
cells influence the activity of thyroid follicular cells via a
paracrine pathway involving regulatory peptides. Thus,
some effects, such as the stimulative action of serotonin
secreted from C-cells on TH release (Kalisnik et al. 1990), can
be suppressed by inhibiting the thyroid C-cell population.
It is known that changes in TH status can alter bone meta-
bolism (Murphy & Williams, 2004). Thyroid hormones stimu-
late osteoclastic bone resorption directly through nuclear
TH receptors a and b (Mundy et al. 1976; Kanatani et al.
2004). In vitro data indicate that TH affect bone either by
direct action on osteoclasts or by activating osteoblasts,
which then release a receptor activator for nuclear factor
kappa-B ligand (Britto et al. 1994). The thyroid gland
hypoactivity and marked decrease in serum T4 after salmon
CT treatment found here suggest that exogenous CT, in
addition to directly stimulating trabecular bone formation,
may affect the activity of the TH-producing cell population
in the thyroid. Mechanisms by which CT act on the thyroid
gland are still unclear. Thyroid C-cells are mostly localized in
central regions of the thyroid gland lobes, where TH synthe-
sis and secretion seem to be higher than in the periphery. It
is probable that regulatory peptides produced by C-cells
may participate in controlling thyroid activity by a direct
paracrine route. Consequently, the possible mechanism of
action may include this potential paracrine stimulation of
follicular cells by thyroid C-cells. In our experimental condi-
tions, the exogenous CT induced strong inhibition of thy-
roid C-cells and may be associated with the absence of
paracrine stimulation of thyroid follicular cells.
In summary, in our animal model of male osteoporosis,
salmon CT treatment decreased bone turnover and deterio-
ration of bone structure. However, exogenous CT strongly
inhibited thyroid C-cells, accompanied by an influence on
structural and functional features of thyroid follicular cells.
Thyroid follicular cell hypoactivity after exogenous CT appli-
cation may additionally contribute to the beneficial effect
of such treatment on trabecular bone mass. This is the first
report which opens the possibility, among others, that,
besides direct action on the skeleton, exogenous CT may
affect trabecular bone structure indirectly through changes
in thyroid follicular cell activity caused by potential inhibi-
tion of C-cell paracrine regulation.
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